These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

978 related items for PubMed ID: 27779717

  • 21. LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway.
    Wang X, Zhang Y, Zheng J, Yao C, Lu X.
    Cancer Immunol Immunother; 2021 Aug; 70(8):2235-2245. PubMed ID: 33486611
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.
    Liu J, Feng L, Zhang H, Zhang J, Zhang Y, Li S, Qin L, Yang Z, Xiong J.
    Cancer Biol Ther; 2018 Jun 03; 19(6):484-496. PubMed ID: 29504819
    [Abstract] [Full Text] [Related]

  • 28. Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity.
    Zhu X, Zhao L, Doolittle WKL, Cheng SY.
    Endocr Relat Cancer; 2023 Jun 01; 30(6):. PubMed ID: 36939877
    [Abstract] [Full Text] [Related]

  • 29. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
    Zhang W, Ji W, Zhao X.
    BMC Cancer; 2019 Nov 12; 19(1):1093. PubMed ID: 31718618
    [Abstract] [Full Text] [Related]

  • 30. Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway.
    Tong AH, Tan J, Zhang JH, Xu FJ, Li FY, Cao CY.
    J Biochem Mol Toxicol; 2019 Feb 12; 33(2):e22241. PubMed ID: 30431689
    [Abstract] [Full Text] [Related]

  • 31. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
    Tuysuz EC, Gulluoglu S, Yaltirik CK, Ozbey U, Kuskucu A, Çoban EA, Sahin F, Türe U, Bayrak OF.
    Exp Cell Res; 2019 Jul 01; 380(1):9-19. PubMed ID: 30951707
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Kimura T, Doolittle WKL, Kruhlak M, Zhao L, Hwang E, Zhu X, Tang B, Wolcott KM, Cheng SY.
    Thyroid; 2024 Apr 01; 34(4):484-495. PubMed ID: 38115586
    [Abstract] [Full Text] [Related]

  • 33. miR-199a-5p suppresses epithelial- mesenchymal-transition in anaplastic thyroid carcinoma cells via targeting Snail signals.
    Hao F, Bi YN, Wang L, Wang Y, Ma J, Cui P, Li X, Sun S, Ning L, Huang Y, Jiao X, Chen D.
    Cancer Biomark; 2020 Apr 01; 29(3):317-326. PubMed ID: 32716347
    [Abstract] [Full Text] [Related]

  • 34. miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
    Shao M, Geng Y, Lu P, Xi Y, Wei S, Wang L, Fan Q, Ma W.
    Biochem Biophys Res Commun; 2015 Sep 04; 464(4):1309-1313. PubMed ID: 26231799
    [Abstract] [Full Text] [Related]

  • 35. Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs.
    Xu Y, Xie Y, Wang X, Chen X, Liu Q, Ying M, Zheng Q.
    Oncol Rep; 2013 Nov 04; 30(5):2056-62. PubMed ID: 24002436
    [Abstract] [Full Text] [Related]

  • 36. Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin.
    Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L, Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, Ming ZJ, Li B, Chen B, Wang JR, Liu YB, Yang JM.
    Biochem Pharmacol; 2014 Feb 15; 87(4):562-70. PubMed ID: 24345332
    [Abstract] [Full Text] [Related]

  • 37. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
    Zhu X, Park S, Lee WK, Cheng SY.
    Endocr Relat Cancer; 2019 Sep 15; 26(9):739-750. PubMed ID: 31272080
    [Abstract] [Full Text] [Related]

  • 38. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.
    Int J Oncol; 2012 Mar 15; 40(3):747-56. PubMed ID: 22025269
    [Abstract] [Full Text] [Related]

  • 39. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer.
    Wang Y, Hu Z, Ma W, Niu Y, Su J, Zhang L, Zhao P.
    Invest New Drugs; 2021 Jun 15; 39(3):764-774. PubMed ID: 33245464
    [Abstract] [Full Text] [Related]

  • 40. C5AR1-induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer.
    Liu B, Sun Y, Geng T, Wang H, Wu Z, Xu L, Zhang M, Niu X, Zhao C, Shang J, Shang F.
    Mol Carcinog; 2024 Oct 15; 63(10):1938-1952. PubMed ID: 38934768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.